TABLE 2.
One-Year Incidence of Health Problems
Pre-Pandemic Cohort | Peri-Pandemic Cohort | Standardized Incidence Ratio | |||
N | Incidence | N | Incidence | 95% CI | |
Male | |||||
Overweight | 22,790 | 1,101 | 13,912 | 874 | 1.30 |
4.8% | 6.3% | 1.21–1.38 | |||
Hypertension | 29,112 | 1,868 | 17,801 | 1,395 | 1.21 |
6.4% | 7.8% | 1.15–1.27 | |||
Hypercholesterolemia | 24,047 | 3,186 | 14,608 | 1,678 | 0.86 |
13.2% | 11.5% | 0.82–0.90 | |||
Hyperglycemia | 28,549 | 1,345 | 17,517 | 967 | 1.17 |
4.7% | 5.5% | 1.09–1.24 | |||
Liver damage | 28,187 | 1,696 | 17,334 | 1,545 | 1.48 |
6.0% | 8.9% | 1.41–1.55 | |||
Female | |||||
Overweight | 21,036 | 474 | 13,568 | 374 | 1.22 |
2.3% | 2.8% | 1.09–1.34 | |||
Hypertension | 23,379 | 557 | 15,183 | 434 | 1.19 |
2.4% | 2.9% | 1.07–1.30 | |||
Hypercholesterolemia | 20,000 | 1,859 | 12,680 | 926 | 0.78 |
9.3% | 7.3% | 0.73–0.84 | |||
Hyperglycemia | 22,621 | 694 | 14,966 | 532 | 1.15 |
3.1% | 3.6% | 1.06–1.25 | |||
Liver damage | 23,808 | 285 | 15,545 | 309 | 1.65 |
1.2% | 2.0% | 1.47–1.84 |